Events
12:30 - 17:45
This was 1 year ago
Permanent Representation of Estonia to the EU, Brussels
Rue Guimard 11/13, 1040 Brussels, Belgium
Estonian Research Council Brussels Office and ScanBalt® are organising a seminar on the 13th of May 2025 to address the pressing need for innovation in the early diagnosis of Alzheimer’s and Parkinson’s disease.
Policymakers, industry experts and academia will collaborate to explore how to bridge policy, technology and healthcare for the future of neurogenerative disease diagnosis and care in Europe.
The seminar (12:30-17:45) will be followed by a networking reception (17:45-18:30).
You can find more information and the registration link here.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
The ERC is inviting expressions of interest from current ERC grantees for a one-day science communication training taking place in Brussels. Interested ERC grantees are invited to complete the online expression of interest form. The deadline for applications is 24 August 2026 12 pm CEST. Notification of selected participants (approximately 40) is...
Read moreThe project VALLEYS aims to strengthen knowledge valorisation in Europe by building a network of knowledge valorisation intermediaries connecting more than 150 organisations from over 25 countries, empowering organisations such as TTOs, incubators, science parks, clusters, and citizen engagement entities to adopt and scale the EU Guiding Principles...
Read moreEIC-backed health biotech companies ready to pitch their innovation to investors can Apply for the EIC VentureMatch Pitching on Health Biotech during BIO-Europe.The investor panel includes: NRW.BANK, LifeArc Ventures, DeepTech & Climate Fonds (DTCF), Apollo Health Ventures, Forbion, Bayern Kapital, M Ventures.Organised under the EIC...
Read moreThis one-day pre-conference is organised by the Transforming Health and Care Systems (THCS) Partnership as part of the European Public Health Conference programme. The conference will focus on how health and care systems can respond to climate, equity and innovation challenges.
Read moreTestimonial
ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.
ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.
